Background Late-onset noninfectious pulmonary complications (LONIPCs) are life-threatening complications of bone marrow transplantation (BMT). Several pathological patterns are described in the literature with different prognoses, and with different relationships to graft-versushost disease (GVHD). The role of high-resolution CT (HRCT) is not yet well established. Objective To illustrate different patterns of LONIPCs on HRCT in allogeneic versus autologous BMT in order to investigate the correlation with chronic GVHD (cGVHD). Materials and methods A total of 67 HRCT scans were performed in 24 patients with noninfectious pulmonary disease at least 3 months after BMT (16 allogeneic, 8 autologous). Abnormality patterns and extension on HRCT images were correlated with the clinical outcome and with the severity of cGVHD.
Introduction
Pulmonary complications after bone marrow transplantation (BMT) occur in 25% of children [1] , and are responsible for decreased survival time and increased mortality. There has been a decrease in infectious complications due to the widespread use of infection prophylaxis, and noninfectious complications are now the major pulmonary cause of morbidity and mortality in patients after BMT [2] . In particular, late-onset noninfectious pulmonary complications (LONIPCs) occurring beyond 3 months after BMT have now become recognized as life-threatening complications. The presence of graft-versus-host disease (GVHD) seems to be a contributing factor to the advent of noninfectious pulmonary complications [3] . Furthermore, in children, the occurrence of severe GVHD increases the relative risk of developing pulmonary complications by a factor of two [1] . Diagnosis is crucial since the only available treatment for many noninfectious conditions is increased immunosuppression [4] .
While pulmonary histological confirmation is not always available and bronchoalveolar lavage (BAL) cytology is generally performed in BMT patients to differentiate infectious from noninfectious processes, high-resolution CT (HRCT) is usually a complementary tool, although its specific role in the diagnosis of LONIPCs is not well defined. The pathological spectrum of LONIPCs is still undefined. Palmas et al. [4] proposed that the classification include bronchiolitis obliterans (BO), BO with organizing pneumonia (BOOP), diffuse alveolar damage (DAD), lymphocytic interstitial pneumonia, and nonclassifiable interstitial pneumonia. Afessa et al. [5] categorized LONIPCs as BO, BOOP, and idiopathic pneumonia syndrome. Data in the literature on prognostic significance and the relationship between different pathological spectra and chronic GVHD (cGVHD) are scarce and contradictory, especially in children. Some authors [6, 7] consider BO as the end-stage damage of pulmonary GVHD, preceded by BOOP and idiopathic pneumonia syndrome; others consider subclassifications of LONIPCs as separate entities with different clinical outcomes and different relationships to GVHD.
The aim of this longitudinal study was to compare HRCT findings between paediatric allogeneic BMT patients presenting with respiratory complications and oncology patients with similar clinical symptoms but receiving autologous BMT. We sought to determine whether specific HRCT patterns correlated with the presence of extrapulmonary GVHD in allogeneic BMT patients with different clinical outcomes, and could therefore be helpful for diagnostic purposes and therapeutic interventions.
Materials and methods

Patients
All patients from a paediatric tertiary care teaching hospital presenting with noninfectious respiratory complications at least 3 months after allogeneic and autologous BMT were [8] Respiratory complications were defined as symptoms such as cough, dyspnoea, hypoxaemia, haemoptysis or unexplained fever with respiratory symptoms, or persistent infiltrates on chest radiographs.
HRCT HRCT (Somatom Sensation 40/64, Siemens, Erlangen, Germany; MX 8000, Philips, Best, The Netherlands) was performed at end inspiration using 1-mm collimation at 5-or 10-mm intervals, 90-120 mAs and 100-120 kVp. Two paediatric radiologists analysed the HRCT scans and reached final decisions by consensus with regard to the spatial extent of the lesions (considered as limited when no more than one lung segment was involved), and pattern of abnormality (ground-glass and air-space opacities, bronchial dilatation, bronchial wall thickening, tree-in-bud opacities, reticular opacities, large or small nodules, mosaic attenuation, perfusion). Criteria for these findings were those defined in the Fleischner Society's glossary of terms [9] .
Once a patient was identified as having LONIPCs, we attempted to further classify the disease on the basis of clinical and radiological findings, routine pulmonary function tests when possible, and pathological findings when available, according to Afessa et al. [5] , as BO, BOOP, interstitial pneumonia and DAD. In the literature, patients have been classified as having BO if they show a decline in FEV 1 (forced expired volume in 1 s) of less than 80% of the predicted value and FEV 1 /FVC (forced volume capacity) of less than 70% [10] . However, in young chronically ill children, pulmonary function tests are often not applicable and seldom performed [11] . Signs of BO on HRCT are low-or high-attenuation areas, bronchial dilatation, bronchial thickening, vascular attenuation and [12] . Bullae or pneumothorax are considered consequences of obstructive lung disease [13] . Histologically, BO is recognized by intraluminal fibrosis [14] . Idiopathic pneumonia syndrome is diagnosed if a patient shows bilateral diffuse parenchymal interstitial/ alveolar infiltrates on chest radiographs and/or CT images with associated hypoxaemia (PaO 2 <70 mmHg, A-aDO 2 >20 mmHg) [15] . The diagnosis of DAD requires fulfilment of the following criteria: diffuse bilateral pulmonary infiltrates, progressively haemorrhagic BAL fluid from at least three separate lobes and haemosiderin-laden macrophages on microscopic examination of the BAL fluid, no improvement with correction of underlying coagulopathy, and/or fluid overload and no evidence of cardiogenic pulmonary oedema [4, 16] . BOOP is diagnosed on the basis of the chest radiographic appearance of patchy air-space opacity, foci of air-space consolidation and ground-glass opacity on HRCT images [17] [18] [19] . Pathologically, BOOP is character- 
Results
Study patients
The review of the medical charts identified 27 patients (14 boys) who had undergone BMT between January 2001 and January 2007. Three patients died in the days following the BMT and were excluded from the study. The clinical details for 24 children surviving at least 3 months after allogeneic or autologous BMT are summarized in Table 1 .
Of the 24 patients, 16 underwent allogeneic BMT (6 had related donor BMT and 10 had nonrelated donor BMT) and 4 of these 16 underwent BMT twice. The mean age of the allogeneic BMT patients at the time of transplantation was 9.2 years (range 4.5 months to 17 years) and the mean time between diagnosis and BMT was 1.7 years (range 0.2-7 years). Over the same time period, eight patients underwent autologous BMT and one had two BMTs. Their mean age was 10 years (range 3.1-15.3 years) and the mean time between diagnosis and BMT was 1.5 years (range 0.5-3 years).
The conditioning regimen included chemotherapy and TBI at a total dose of 12 Gy in eight patients (all allogeneic BMT), chemotherapy and cranial irradiation in one patient (allogeneic BMT) and chemotherapy alone in 15 patients (7 allogeneic and 8 autologous BMT). Autologous BMT patients did not receive TBI, but some had radiotherapy for their underlying pathology before the transplantation. Mean methotrexate dose was not significantly different between allogeneic and autologous BMT patients (1,363 mg/m 2 and 2,047 mg/m 2 , respectively; P=NS). Cyclosporine A was uniformly started at a dose of 3 mg/kg per day intravenously on day 1, and then was adjusted according to blood levels. The overall characteristics of the two groups of patients were similar.
Of the 16 patients, 12 presented with respiratory symptoms or chest radiographic anomalies at least 3 months after allogeneic BMT and underwent 43 HRCT scans, and 8 of the 16 patients (50%) had HRCT evidence of LONIPCs. All of the eight autologous BMT patients had HRCT scans (24 HRCT scans in total) on follow-up of the underlying diseases. One of the eight (12.5%) had HRCT evidence of LONIPCs. Thus the overall percentage of LONIPCs in our patients was of 37.5%. In the group of children who had two BMTs (4 allogeneic and 1 autologous), 3 developed LONIPCs, while of the 19 patients who underwent only one BMT, 5 had LONIPCs.
Of the 16 patients, 7 did not develop GVHD; 2 had LONIPCs. Five patients had mild GVHD (stage I/II), of whom two had LONIPCs. Four had severe GVHD (stage III/ IV) and all of them had LONIPCs. All patients with moderateto-severe GVHD had at least skin and gastrointestinal involvement. All four patients with severe GVHD died.
HRCT
A total of 67 HRCT scans were performed in 20 patients (1-8 studies per patient). The patterns of abnormalities on HRCT in the nine patients with LONIPCs are summarized in Table 2 . The pattern and the extension of CT findings were variable. Interstitial thickening was shown in all nine patients. The only patient with autologous BMT and abnormalities on HRCT had marked interstitial thickening (Fig. 1) in strict spatial correlation with therapeutic radiation.
On the basis of HRCT it was impossible to subclassify patients with LONIPCs (BO, interstitial pneumonia, DAD, BOOP). None of the patients fulfilled the clinical and CT definitions for BO. Three of four patients with GVHD had bullae (Fig. 2 ) and unilateral pneumothorax (Fig. 2) . However, patients with GVHD did not show a specific pattern of abnormalities on HRCT (Table 2 ). In the patient with DAD, the pattern on HRCT, severe GVHD and poor clinical outcome are in accordance with reports in the literature [4, 16] . In this patient the lung abnormalities were extensive (Fig. 3) . Two patients were classified as having BOOP on the basis of clinical and CT findings; lung parenchyma involvement was extensive (Fig. 4) . In the two patients who had allogeneic BMT and mild GVHD, the clinical course was satisfactory (Fig. 5) .
Statistics
There was no statistically significant difference in the incidence of LONIPCs between patients after one or multiple BMTs (P=0.2), nor between patients receiving TBI or chemotherapy only as the conditioning regimen (P= 0.26). There was no statistically significant association between the presence of GVHD and a diagnosis of LONIPCs on HRCT (P=0.16). However, there was a significant association between abnormalities on HRCT and severe GVHD (P=0.038; Table 3 ). All patients with severe GVHD died. The association between severe GVHD (stage III/IV) and death was significant (P=0.002; Table 4 ).
Discussion
The current longitudinal study is the first in the paediatric literature to investigate the incidence of LONIPCs on HRCT in allogeneic versus autologous BMT in order to ascertain whether a correlation exists with GVHD [21]. The incidence of LONIPCs was higher than that reported previously (range 3-26%) [22] [23] [24] . This can be partially explained by the relative homogeneity of the patients in our series in contrast with other studies that included adults and different conditioning regimens. LONIPCs are found almost exclusively in patients with allogeneic rather than autologous BMT [1, 13, 25] . In fact, the only patient (one of eight) with abnormalities on HRCT after autologous BMT had interstitial thickening following local radiation, thus probably not directly related to the BMT.
The patients in the two groups were relatively homogeneous (Table 3 ). The only significant association was with the presence of severe GVHD (P=0.038), confirming the belief that the lung can be a target of GVHD [3] . The spatial extension of abnormalities on HRCT was not correlated with either GVHD or with clinical outcome. In fact, the two patients with extensive ground-glass opacities and consolidations were the only two without GVHD and had a very good outcome. These two children had been diagnosed with BOOP on the basis of HRCT and clinical findings. Our study supports reports in the literature that BOOP is not a manifestation of GVHD [26] and usually has a good outcome. On the contrary, most patients with abnormalities on HRCT associated with severe GVHD and a poor outcome showed limited spatial extension (Fig. 2) . There was no correlation between a specific pattern and the presence or severity of GVHD, or with the clinical outcome in those with pulmonary pathology, although bullae and pneumothorax tended to show an association with severe GVHD (Table 2) .
We investigated the possibility of subclassifying LONIPCs into BO, BOOP and interstitial pneumonia according to the classification of Afessa et al. [5] , which could be important in predicting the clinical outcome. This subclassification was not possible on the basis of HRCT findings alone. However, HRCT findings combined with clinical data and BAL results may be of real value in narrowing the differential diagnosis. For instance, in our series no patient fulfilled all the criteria for the diagnosis of BO, probably because they were too young or their clinical condition was too poor to perform accurate pulmonary function tests [11] . The finding of bullae or pneumothorax on HRCT is regarded as indirect evidence of BO or interstitial pneumonia. All of the patients with bullae and pneumothorax had GVHD and the clinical outcome was unfavourable. Also, in the only patient with DAD, the correct diagnosis resulted from the combination of clinical data, BAL and HRCT findings. The association of DAD with severe GVHD and poor clinical outcome is well described in the literature [4, 16] and was also found in our patient. All patients with severe GVHD died, verifying the significant association between severe GVHD (stage III/IV) and death (P=0.02).
The clinical symptoms of LONIPCs may be insidious at the beginning of the disease, and routine radiological examination may also be normal. Furthermore, in LONIPCs, response to immunosuppressive therapy is limited, the best outcome being preservation of remaining lung function rather than significant improvement [14] . Since enhanced immunosuppression increases the risk of infection, the utility of such therapy is questionable when pulmonary dysfunction is chronic. Thus it is of the utmost importance to perform HRCT early in order to suggest the diagnosis of LONIPCs. Further prospective studies are required to determine the role of HRCT in patients with GVHD before the development of LONIPC-related respiratory symptoms.
Conclusion
The significant association between HRCT abnormalities and severe cGVHD (grades III/IV) suggests that LONIPCs can be a pulmonary manifestation of the disease. The prognosis seems to be related to the severity of GVHD and not to the pattern or extension of HRCT abnormalities. The accurate diagnosis of LONIPC subclasses is not possible on the basis of HRCT alone. However, HRCT combined with clinical data and BAL assists in narrowing the differential diagnosis and establishing the prognosis. 
